Concurrent radiotherapy and chemotherapy for locally advanced squamous cell carcinoma of the head and neck

Head and Neck Oncology

Volumn 3, Issue 1, 2011, Pages

  Ali, Elsayed M ^a   Abdelraheem, Ahmad G ^b  

^a Sohag University   (Egypt)

^b South Valley University   (Egypt)

Author keywords

chemoradiation; gemcitabine; head and neck cancer; locally advanced; radiotherapy; squamous cell carcinoma

Indexed keywords

GEMCITABINE; ANTINEOPLASTIC AGENT; DEOXYCYTIDINE; DRUG DERIVATIVE; RADIOSENSITIZING AGENT;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BLOOD TOXICITY; CANCER REGRESSION; CANCER STAGING; CANCER SURGERY; CHEMORADIOTHERAPY; DISEASE FREE SURVIVAL; DISEASE SEVERITY; DRUG EFFICACY; DYSPHAGIA; FEASIBILITY STUDY; FEMALE; FOLLOW UP; HEAD AND NECK CARCINOMA; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; NEUTROPENIA; OUTCOME ASSESSMENT; PATIENT SAFETY; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROSPECTIVE STUDY; RADIATION DOSE; SALVAGE THERAPY; SKIN TOXICITY; SQUAMOUS CELL CARCINOMA; TREATMENT DURATION; TREATMENT RESPONSE; XEROSTOMIA; CLINICAL TRIAL; HEAD AND NECK TUMOR; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PATHOLOGY;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; DEOXYCYTIDINE; DISEASE-FREE SURVIVAL; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RADIATION-SENSITIZING AGENTS; YOUNG ADULT;

EID: 81055126969     PISSN: None     EISSN: 17583284     Source Type: Journal    
DOI: 10.1186/1758-3284-3-48     Document Type: Article

References (12)

1. Global cancer statistics in the year 2000. Parkin DM, Lancet Oncol 2001 2 533 543 10.1016/S1470-2045(01)00486-7 11905707 (Pubitemid 33586866)
2. Combined modality therapy of head and neck cancer. Stupp R, Weichselbaum RR, Vokes EE, Semin Oncol 1994 21 349 358 8209266 (Pubitemid 24191594)
3. Medical treatment in head and neck cancer. Vermorken JB, Ann Oncol 2005 16 258 264
4. Concomitant chemoradiotherapy as primary therapy for loco regionally advanced head and neck cancer. Vokes EE, Kies MS, Haraf DJ, Stenson K, List M, Humerickhouse R, Dolan ME, Pelzer H, Sulzen L, Witt ME, Hsieh YC, Mittal BB, Weichselbaum RR, J Clin Oncol 2000 18 1652 1661 10764425 (Pubitemid 30220543)
5. simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: a randomized multicenter trial. Wendet TG, Grabenbauer GG, Rodel CM, Thiel HJ, Aydin H, Rohloff R, Wustrow TP, Iro H, Popella C, Schalhorn A, J Clin Oncol 1998 16 1318 1324 9552032 (Pubitemid 28175746)
6. Update of MACH-NC (Meta-analysis of Chemotherapy in Head and Neck Cancer) data base focused on concomitant chemoradiotherapy. Bourhis J, Armand JP, Pignon P, J Clin Oncol 2004 22 145 5505
7. A phase III comparison of standard radiation therapy versus split course radiotherapy plus concurrent cisplatin versus radiotherapy plus cisplatin and 5-fluorouracil in patients with unresectable squamous cell head and neck cancer: an intergroup study. Adelstein DJ, Adams GL, Wagner H, Kish J, Ensley J, Schuller D, Forastiere A, Proc Am Soc Clin Oncol 2000 19 bst 1624
8. radiosensitization of pancreatic cancer cells by 2, 2-difluoro-2- deoxycytidine. Lawrence TS, Chang EY, Hahn TM, Hertel LW, Shewach DS, Int J Radiat Oncol Biol Phys 1996 34 867 872 10.1016/0360-3016(95)02134-5 8598364
9. Radiation concurrent with gemcitabine for locally advanced head and neck cancer: a phase I trial and intracellular drug incorporation study. Eisbruch A, Shewach DS, Bradford CR, J Clin Oncol 2001 19 3 792 799 11157033 (Pubitemid 32119095)
10. Phase II trial of gemcitabine concurrent with radiation for locally advanced squamous cell carcinoma of the head and neck. Aguilar-Ponce J, Granados-Garcia M, Villavicencio V, Poitevin-Chacon A, Green D, Duenas-Gonzalez A, Herrera-Gomez A, Luna-Ortiz K, Alvarado A, Martinez-Said H, Castillo-Henkel C, Segura-Pacheco B, De La Garza J, Annals of Oncology 2004 15 301 306 10.1093/annonc/mdh071 14760126 (Pubitemid 38262632)
11. A phase II of gemcitabine concurrent with radiation in locally advanced squamous cell carcinoma of head and neck: A trial of the Cancer Research Group Pakistan. Shaharyar, Javed AA, Shah IH, Ansan TN, Rasool S, Faheem M, Mehmood H, Shah MA, Khan MS, Afridi MA, Pakistan Journal of Medical Sciences 2006 22 3 258 264 (Pubitemid 44411568)
12. gemcitabine concurrent with radiation therapy for locally advanced head and neck carcinoma. Chauhan A, Singh H, Sharma T, Manocha KK, Afr Health Sci 2008 8 3 149 155 19357741